<?xml version="1.0" encoding="UTF-8"?><edgarSubmission xmlns="http://www.sec.gov/edgar/schedule13g" xmlns:com="http://www.sec.gov/edgar/common">
  <headerData>
    <submissionType>SCHEDULE 13G/A</submissionType>
    <filerInfo>
      <filer>
        <filerCredentials>
          <cik>0002058093</cik>
          <ccc>XXXXXXXX</ccc>
        </filerCredentials>
      </filer>
      <liveTestFlag>LIVE</liveTestFlag>



    </filerInfo>
  </headerData>
  <formData>
    <coverPageHeader>
      <amendmentNo>1</amendmentNo>
      <securitiesClassTitle>Common Stock</securitiesClassTitle>
      <eventDateRequiresFilingThisStatement>12/31/2025</eventDateRequiresFilingThisStatement>
      <issuerInfo>
        <issuerCik>0001868279</issuerCik>
        <issuerName>ArriVent BioPharma, Inc.</issuerName>
        <issuerCusip>04272N102</issuerCusip>
        <issuerPrincipalExecutiveOfficeAddress>
          <com:street1>18 CAMPUS BLVD.</com:street1>
          <com:street2>SUITE 100</com:street2>
          <com:city>NEWTOWN SQUARE</com:city>
          <com:stateOrCountry>PA</com:stateOrCountry>
          <com:zipCode>19073-3269</com:zipCode>
        </issuerPrincipalExecutiveOfficeAddress>
      </issuerInfo>
      <designateRulesPursuantThisScheduleFiled>
        <designateRulePursuantThisScheduleFiled>Rule 13d-1(d)</designateRulePursuantThisScheduleFiled>
      </designateRulesPursuantThisScheduleFiled>
    </coverPageHeader>
    <coverPageHeaderReportingPersonDetails>

      <reportingPersonName>INFINITUM ASSET MANAGEMENT, LLC</reportingPersonName>
      <citizenshipOrOrganization>FL</citizenshipOrOrganization>
      <reportingPersonBeneficiallyOwnedNumberOfShares>
        <soleVotingPower>4123923.00</soleVotingPower>
        <sharedVotingPower>0.00</sharedVotingPower>
        <soleDispositivePower>4123923.00</soleDispositivePower>
        <sharedDispositivePower>0.00</sharedDispositivePower>
      </reportingPersonBeneficiallyOwnedNumberOfShares>
      <reportingPersonBeneficiallyOwnedAggregateNumberOfShares>4123923.00</reportingPersonBeneficiallyOwnedAggregateNumberOfShares>
      <classPercent>9.9</classPercent>
      <typeOfReportingPerson>IA</typeOfReportingPerson>
    </coverPageHeaderReportingPersonDetails>
    <coverPageHeaderReportingPersonDetails>

      <reportingPersonName>Infinitum Partners GP, LLC</reportingPersonName>
      <citizenshipOrOrganization>E9</citizenshipOrOrganization>
      <reportingPersonBeneficiallyOwnedNumberOfShares>
        <soleVotingPower>4123923.00</soleVotingPower>
        <sharedVotingPower>0.00</sharedVotingPower>
        <soleDispositivePower>4123923.00</soleDispositivePower>
        <sharedDispositivePower>0.00</sharedDispositivePower>
      </reportingPersonBeneficiallyOwnedNumberOfShares>
      <reportingPersonBeneficiallyOwnedAggregateNumberOfShares>4123923.00</reportingPersonBeneficiallyOwnedAggregateNumberOfShares>
      <classPercent>9.9</classPercent>
      <typeOfReportingPerson>PN</typeOfReportingPerson>
    </coverPageHeaderReportingPersonDetails>
    <coverPageHeaderReportingPersonDetails>

      <reportingPersonName>Infinitum Cayman Master, Ltd.</reportingPersonName>
      <citizenshipOrOrganization>E9</citizenshipOrOrganization>
      <reportingPersonBeneficiallyOwnedNumberOfShares>
        <soleVotingPower>4123923.00</soleVotingPower>
        <sharedVotingPower>0.00</sharedVotingPower>
        <soleDispositivePower>4123923.00</soleDispositivePower>
        <sharedDispositivePower>0.00</sharedDispositivePower>
      </reportingPersonBeneficiallyOwnedNumberOfShares>
      <reportingPersonBeneficiallyOwnedAggregateNumberOfShares>4123923.00</reportingPersonBeneficiallyOwnedAggregateNumberOfShares>
      <classPercent>9.9</classPercent>
      <typeOfReportingPerson>PN</typeOfReportingPerson>
    </coverPageHeaderReportingPersonDetails>
    <items>
      <item1>
        <issuerName>ArriVent BioPharma, Inc.</issuerName>
        <issuerPrincipalExecutiveOfficeAddress>18 CAMPUS BLVD., SUITE 100, NEWTOWN SQUARE, PENNSYLVANIA, 19073-3269.</issuerPrincipalExecutiveOfficeAddress>
      </item1>
      <item2>
        <filingPersonName>Infinitum Cayman Master Ltd (Fund)
Infinitum Asset Management LLC (Asset Manager)
Infinitum Partners GP, LLC (GP)</filingPersonName>
        <principalBusinessOfficeOrResidenceAddress>201 E Las Olas Blvd, Suite 1140 Fort Lauderdale, FL 33301</principalBusinessOfficeOrResidenceAddress>
        <citizenship>Infinitum Cayman Master Ltd, Cayman Islands
Infinitum Asset Management LLC, Delaware
Infinitum Partners GP, LLC, Delaware</citizenship>
      </item2>
      <item3>
        <notApplicableFlag>Y</notApplicableFlag>
      </item3>
      <item4>
        <amountBeneficiallyOwned>Infinitum Cayman Master Ltd 4,123,923
Infinitum Asset Management LLC 4,123,923
Infinitum Partners GP, LLC 4,123,923</amountBeneficiallyOwned>
        <classPercent>Infinitum Cayman Master Ltd 9.9%
Infinitum Asset Management LLC 9.9%
Infinitum Partners GP, LLC 9.9%</classPercent>
        <numberOfSharesPersonHas>
          <solePowerOrDirectToVote>Infinitum Cayman Master Ltd 4,123,923
Infinitum Asset Management LLC 4,123,923
Infinitum Partners GP, LLC 4,123,923</solePowerOrDirectToVote>
          <sharedPowerOrDirectToVote>Infinitum Cayman Master Ltd 0
Infinitum Asset Management LLC 0
Infinitum Partners GP, LLC 0</sharedPowerOrDirectToVote>
          <solePowerOrDirectToDispose>Infinitum Cayman Master Ltd 4,123,923
Infinitum Asset Management LLC 4,123,923
Infinitum Partners GP, LLC 4,123,923</solePowerOrDirectToDispose>
        </numberOfSharesPersonHas>
      </item4>
      <item5>
        <notApplicableFlag>Y</notApplicableFlag>
      </item5>
      <item6>
        <notApplicableFlag>Y</notApplicableFlag>
      </item6>
      <item7>
        <notApplicableFlag>Y</notApplicableFlag>
      </item7>
      <item8>
        <notApplicableFlag>Y</notApplicableFlag>
      </item8>
      <item9>
        <notApplicableFlag>Y</notApplicableFlag>
      </item9>
      <item10>
        <notApplicableFlag>N</notApplicableFlag>
        <certifications>By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under ? 240.14a-11.

</certifications>
      </item10>
    </items>
    <signatureInformation>
      <reportingPersonName>INFINITUM ASSET MANAGEMENT, LLC</reportingPersonName>
      <signatureDetails>
        <signature>John Yetimoglu</signature>
        <title>Chief Investment Officer</title>
        <date>02/17/2026</date>
      </signatureDetails>
    </signatureInformation>
    <signatureInformation>
      <reportingPersonName>Infinitum Partners GP, LLC</reportingPersonName>
      <signatureDetails>
        <signature>John Yetimoglu</signature>
        <title>Chief Investment Officer</title>
        <date>02/17/2026</date>
      </signatureDetails>
    </signatureInformation>
    <signatureInformation>
      <reportingPersonName>Infinitum Cayman Master, Ltd.</reportingPersonName>
      <signatureDetails>
        <signature>John Yetimoglu</signature>
        <title>Chief Investment Officer</title>
        <date>02/17/2026</date>
      </signatureDetails>
    </signatureInformation>
  </formData>
</edgarSubmission>
